Month: June 2012

Daily Preventative Therapies Can Reduce Migraine

by

The American Academy of Neurology/American Headache Society Guidelines released earlier in April 2012, provide evidence-based and effective treatments that can prevent migraine attacks and lessen their severity. They state 38% of migraine sufferers require preventive therapy, but just 3%  to 13% currently use any preventatives. Some patients are taking preventatives that have never been shown to work. The guidelines show that prevention of migraines requires daily medication. Mark Green, MD, director of the Headache Center at Mount Sinai School of Medicine, in New York says “If these guidelines are used widely, we will be able to up the odds of reducing headaches by 50 percent…Evidence is building to suggest that if we allow migraines to progress, the frequency of attacks may increase, and they may also become harder to treat.” The guidelines panel found the following: • The anti-seizure medications … Read more

Botox Injections Have Benefit for Chronic Headaches

by

A new review and analysis of previous studies has found that botulinum toxin A (“Botox”) injections have a small to modest benefit for those with chronic migraine headaches and chronic daily headache. Botulinum toxin A injections were first proposed as headache treatment when it was observed that patients with chronic headaches receiving cosmetic botulinum injections experienced headache improvement, prompting several case series that suggested benefit. Jeffrey L. Jackson, M.D., M.P.H., of the Medical College of Wisconsin, Milwaukee, and colleagues performed a review and meta-analysis to assess the association of botulinum toxin A with reducing headache frequency when used for preventive treatment of migraine, tension, or chronic daily headaches in adults. In the study, headaches were categorized as episodic (less than 15 headaches per month) or chronic (15 or more headaches per month) migraine and episodic or chronic daily or tension … Read more

Reconsideration of decision making for third molar extraction

by

An article recently appeared in the Journal of the Korean Association of Oral and Maxillofacial Surgery titled “Reconsideration of decision making for third molar extraction, “(vol. 37, pages  343-348, 2011) by Wonse Park and et al. I am unable to read the article since it is in Korean but the abstract is in English. The introduction of the article states “Third molar extraction is one of the most common procedures in oral and maxillofacial surgery. The impacted third molar causes many pathological conditions, such as pericoronitis, caries, periodontitis, resorption of adjacent teeth, and cyst or tumors associated with impacted teeth. Extraction is often considered the treatment of choice for impacted lower third molars. On the other hand, imprudent extraction of deeply impacted third molars can cause permanent complications, such as inferior alveolar nerve damage. Therefore, guidelines for the extraction of … Read more

The Body Fights Gum Disease Better When You Are Not Fat

by

An interesting study was conducted by researchers at Case Western Reserve University School of Dental Medicine. The study included 31 obese people with gum disease. Half of those in the group with an average BMI of 39 had gastric bypass surgery and had had fat cells from the abdomen removed. This half did better than a control group of people with an average BMI of 35 who did not have gastric bypass surgery or had fat removed. It was stated that “All study participants underwent nonsurgical periodontal treatments of scaling/root planing and oral hygiene instructions for home care. While both groups showed improvement, the surgery group did even better on the measures for periodontal attachment, bleeding, probing depths and plaque levels.” Periodontal disease is a potential risk of keeping wisdom teeth and is discussed in more detail over at http://www.teethremoval.com/risks_of_keeping_wisdom_teeth.html. Periodontal disease has … Read more

Should There Be a Direct-to-Consumer Pharmaceutical Advertising Ban

by

An interesting article is written by Lia Mulligan titled “You Can’t Say That on Television: Constitutional Analysis of a Direct-to-Consumer Pharmaceutical Advertising Ban,” which appeared in the 2011 issue of the American Journal of Law and Medicine (vol. 37, pages 444-467). In the article it is mentioned that the average american will watch around 16 hours of pharmaceutical advertisements on TV a year. As mentioned I believe before on this blog the U.S. and New Zealand are the only 2 countries in the world that even allow direct to consumer pharmaceutical advertising (DTCA). I personally do not like this type of advertising and neither do some of my friends. We often make fun of the advertisements when they come on TV as they sometimes can be quite silly. The article mentions in 1969 when the FDA first issued regulations for … Read more